Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | pyruvate kinase | 0.0441 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Echinococcus granulosus | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.0815 | 0.0815 |
Mycobacterium ulcerans | hypothetical protein | 0.0185 | 0.3099 | 0.3099 |
Mycobacterium ulcerans | pyruvate phosphate dikinase | 0.0185 | 0.3099 | 0.3099 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.1967 | 0.1967 |
Echinococcus multilocularis | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0441 | 1 | 0.5 |
Plasmodium falciparum | pyruvate kinase | 0.0441 | 1 | 1 |
Giardia lamblia | Pyruvate kinase | 0.0226 | 0.4226 | 0.1633 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0308 | 0.641 | 0.6166 |
Echinococcus granulosus | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Leishmania major | pyruvate phosphate dikinase, putative | 0.0185 | 0.3099 | 0.3099 |
Mycobacterium tuberculosis | Probable pyruvate, phosphate dikinase PpdK | 0.0185 | 0.3099 | 0.3099 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0441 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Echinococcus multilocularis | pyruvate kinase | 0.0441 | 1 | 1 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0441 | 1 | 1 |
Brugia malayi | pyruvate kinase, muscle isozyme | 0.0093 | 0.0636 | 0.0636 |
Loa Loa (eye worm) | hypothetical protein | 0.0308 | 0.641 | 0.6166 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0441 | 1 | 1 |
Leishmania major | pyruvate kinase | 0.0441 | 1 | 1 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0441 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | pyruvate phosphate dikinase | 0.0185 | 0.3099 | 0.5 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0441 | 1 | 1 |
Brugia malayi | pyruvate kinase | 0.0093 | 0.0636 | 0.0636 |
Mycobacterium ulcerans | pyruvate kinase | 0.0441 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0348 | 0.7501 | 0.7501 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0441 | 1 | 1 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0441 | 1 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0185 | 0.3099 | 0.3099 |
Echinococcus granulosus | pyruvate kinase | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0441 | 1 | 1 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.1967 | 0.1967 |
Leishmania major | pyruvate kinase | 0.0441 | 1 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0226 | 0.4226 | 0.4226 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0441 | 1 | 0.5 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0441 | 1 | 1 |
Treponema pallidum | pyruvate phosphate dikinase | 0.0185 | 0.3099 | 0.5 |
Plasmodium vivax | pyruvate kinase, putative | 0.0441 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0441 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.1967 | 0.1967 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0441 | 1 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0441 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0441 | 1 | 1 |
Brugia malayi | Pyruvate kinase, alpha/beta domain containing protein | 0.0133 | 0.1727 | 0.1727 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0308 | 0.641 | 1 |
Chlamydia trachomatis | pyruvate kinase | 0.0441 | 1 | 1 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0441 | 1 | 1 |
Giardia lamblia | Pyruvate kinase | 0.0441 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (ADMET) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (ADMET) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.